These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1091699

  • 1. Canine marrow transplantation: are serum blocking factors necessary to maintain the stable chimeric state?
    Tsoi MS, Storb R, Weiden PL, Graham TC, Schroeder ML, Thomas ED.
    J Immunol; 1975 Feb; 114(2 Pt 1):531-9. PubMed ID: 1091699
    [Abstract] [Full Text] [Related]

  • 2. Infusion of donor lymphocytes into stable canine radiation chimeras: implications for mechanism of transplantation tolerance.
    Weiden PL, Storb R, Tsoi MS, Graham TC, Lerner KG, Thomas ED.
    J Immunol; 1976 May; 116(5):1212-9. PubMed ID: 774975
    [Abstract] [Full Text] [Related]

  • 3. Studies on cellular inhibition and serum-blocking factors in 28 human patients given marrow grafts from HLA identical siblings.
    Tsoi MS, Storb R, Weiden PL, Thomas ED.
    J Immunol; 1977 May; 118(5):1799-805. PubMed ID: 16061
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Some comments on lymphocyte-mediated cytotoxicity and blocking serum activity in allograft tolerance.
    Hellström I, Hellström KE.
    Johns Hopkins Med J Suppl; 1974 May; 3():301-5. PubMed ID: 4607384
    [No Abstract] [Full Text] [Related]

  • 6. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
    Gammie JS, Li S, Zeevi A, Demetris AJ, Ildstad ST, Pham SM.
    Circulation; 1998 Nov 10; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
    [Abstract] [Full Text] [Related]

  • 7. Induction of allogeneic unresponsiveness in adult dogs. Role of non-DLA histocompatibility variables in conditioning the outcome of bone marrow, kidney, and skin transplantation in radiation chimeras.
    Rapaport FT, Bachvaroff RJ, Watanabe K, Hirasawa H, Mollen N, Ferrebee JW, Amos DB, Cannon FD, Blumenstock DA.
    J Clin Invest; 1978 Mar 10; 61(3):790-800. PubMed ID: 76636
    [Abstract] [Full Text] [Related]

  • 8. Studies on the mechanism of stable graft-host tolerance in canine and human radiation chimeras.
    Storb R, Tsoi MS, Weiden PL, Graham TC, Thomas ED.
    Transplant Proc; 1976 Dec 10; 8(4):561-4. PubMed ID: 11587
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C, Allard A, Brochu S, Poupart C, Fontaine P, Bélanger R, Gyger M.
    Bone Marrow Transplant; 1990 Aug 10; 6(2):127-35. PubMed ID: 2145050
    [Abstract] [Full Text] [Related]

  • 11. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
    Thierfelder S, Rodt H.
    Transplantation; 1977 Jan 10; 23(1):87-92. PubMed ID: 319574
    [Abstract] [Full Text] [Related]

  • 12. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum.
    Weiden PL, Storb R, Slichter S, Warren RP, Sale GE.
    J Immunol; 1976 Jul 10; 117(1):143-50. PubMed ID: 6593
    [Abstract] [Full Text] [Related]

  • 13. Colony inhibition of fibroblasts from chimeric dogs mediated by the dogs' own lymphocytes and specifically abrogated by their serum.
    Hellström I, Hellström KE, Storb R, Thomas ED.
    Proc Natl Acad Sci U S A; 1970 May 10; 66(1):65-71. PubMed ID: 5273902
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Kidney transplantation following treatment with cyclophosphamide and bone marrow grafting.
    von Scheel J, Kolb HJ, Duswald KH, Rieder I, Chaussy C, Grosse-Wilde H, Scholz S, Pielsticker K.
    Transplant Proc; 1977 Mar 10; 9(1):261-3. PubMed ID: 325763
    [Abstract] [Full Text] [Related]

  • 16. Histocompatibility studies in a closely bred colony of dogs.
    Rapaport FT, Watanabe K, Cannon FD, Mollen N, Blumenstock D, Ferrebee JW.
    J Exp Med; 1972 Nov 01; 136(5):1080-97. PubMed ID: 4404277
    [Abstract] [Full Text] [Related]

  • 17. Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
    Deeg HJ, Severns E, Raff RF, Sale GE, Storb R.
    Transplantation; 1987 Nov 01; 44(5):621-32. PubMed ID: 2961110
    [Abstract] [Full Text] [Related]

  • 18. Tolerance to host minor histocompatibility antigens after allogenic bone marrow transplantation. Specific donor-host unresponsiveness is maintained by peripheral tolerizing cells.
    Brochu S, Roy DC, Perreault C.
    J Immunol; 1992 Nov 15; 149(10):3135-41. PubMed ID: 1431092
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic unresponsiveness to orthotopic cardiac transplants in DL-A-identical radiation chimeras.
    Boyd AD, Spencer FC, Hirose H, Engelman RM, Cannon FD, Ferrebee JW, Rapaport FT.
    Transplant Proc; 1975 Dec 15; 7(4):475-7. PubMed ID: 53925
    [Abstract] [Full Text] [Related]

  • 20. Graft-versus-host disease after marrow transplantation.
    Storb R.
    Prog Clin Biol Res; 1986 Dec 15; 224():139-57. PubMed ID: 3540990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.